Potent P2Y12 Inhibitor Therapy for All?

被引：0
|
作者：
Brown, Oliver I. [1 ]
Rossington, Jennifer A. [1 ]
Hoye, Angela [1 ]
机构：
[1] Univ Hull, Hull York Med Sch, Castle Hill Hosp, Dept Acad Cardiol, Castle Rd,Daisy Bldg, Kingston Upon Hull HU16 5JQ, East Yorkshire, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 70卷 / 11期
关键词：
ACUTE CORONARY SYNDROME; CLOPIDOGREL; TICAGRELOR; JAPANESE; PHILO;
D O I：
10.1016/j.jacc.2017.05.079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1425 / 1425
页数：1
相关论文
共 50 条
  • [21] STEMI Antithrombotic Therapy: The Evolving Role of P2Y12 Inhibitor Pretreatment in Contemporary Practice
    Tommasino, Antonella
    Fiorentini, Vincenzo
    Mattaroccia, Giulia
    Scoccia, Alessandra
    Barbato, Emanuele
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (11)
  • [22] INS50589, a potent, selective, and reversible inhibitor of P2Y12 mediated platelet aggregation.
    Douglass, JG
    Patel, RI
    Cowlen, MC
    Yerxa, BR
    Shaver, SR
    Mahanty, S
    Watson, P
    Boyer, JL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U120 - U120
  • [23] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [24] P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention
    Zhou, Xuan
    Angiolillo, Dominick J.
    Ortega-Paz, Luis
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (10)
  • [25] Personalized P2Y12 Inhibitor Treatment Are We Ready to Go?
    ten Berg, Jurrien M.
    Janssen, Paul W. A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (05) : 631 - 633
  • [26] Efficient synthesis of prasugrel, a novel P2Y12 receptor inhibitor
    Pan, Xianhua
    Huang, Rui
    Zhang, Jianshui
    Ding, Liping
    Li, Weijin
    Zhang, Qunhui
    Liu, Feng
    TETRAHEDRON LETTERS, 2012, 53 (40) : 5364 - 5366
  • [27] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [28] P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
    Gragnano, Felice
    Mehran, Roxana
    Branca, Mattia
    Franzone, Anna
    Baber, Usman
    Jang, Yangsoo
    Kimura, Takeshi
    Hahn, Joo-Yong
    Zhao, Qiang
    Windecker, Stephan
    Gibson, Charles M.
    Kim, Byeong-Keuk
    Watanabe, Hirotoshi
    Bin Song, Young
    Zhu, Yunpeng
    Vranckx, Pascal
    Mehta, Shamir
    Hong, Sung-Jin
    Ando, Kenji
    Gwon, Hyeon-Cheol
    Calabro, Paolo
    Serruys, Patrick W.
    Dangas, George D.
    McFadden, Eugene P.
    Angiolillo, Dominick J.
    Heg, Dik
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (06) : 537 - 552
  • [29] The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review
    Chandrasekhar, Jaya
    Hibbert, Benjamin
    Froeschl, Michael
    So, Derek
    Mehran, Roxana
    Le May, Michel
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (01) : 83 - 91
  • [30] The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review
    Jaya Chandrasekhar
    Benjamin Hibbert
    Michael Froeschl
    Derek So
    Roxana Mehran
    Michel Le May
    European Journal of Clinical Pharmacology, 2016, 72 : 83 - 91
12345